human brain microvascular endothelial cells hbmecs (Innoprot Inc)
Structured Review

Human Brain Microvascular Endothelial Cells Hbmecs, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 40 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human brain microvascular endothelial cells hbmecs/product/Innoprot Inc
Average 93 stars, based on 40 article reviews
Images
1) Product Images from "Light-driven repair: Photobiomodulation restores blood–brain barrier function following hypoxic injury"
Article Title: Light-driven repair: Photobiomodulation restores blood–brain barrier function following hypoxic injury
Journal: bioRxiv
doi: 10.64898/2026.02.15.706027
Figure Legend Snippet: A) Experimental workflow illustrating the transwell-based BBB model, hypoxic exposure (6 h, 1% O₂), PBM treatment schedule, and downstream functional and molecular analyses (created with BioRender). (B–E) TEER expressed as relative change (%) from baseline. (B) Normoxic controls at 48 h. (C)TEER immediately following hypoxia. (D)TEER at 24 h post-hypoxia. (E)TEER at 48 h post-hypoxia. PBM significantly restored endothelial barrier resistance under hypoxic conditions. Statistical comparisons were performed using multiple unpaired t-tests with Holm–Šídák correction; N=4 independent biological replicates; *p<0.05. (F)ZO-1 mRNA expression in HBMECs at 48 h, normalised to RPL13A. (G)Quantification of ZO-1 protein levels relative to control, measured as ZO-1-positive area normalised to Hoechst nuclear area. (H)Representative ICC images showing ZO-1 (magenta) and nuclei (Hoechst, blue) in normoxic and hypoxic HBMECs with and without PBM. For mRNA and protein analyses, statistical significance was determined using one-way ANOVA with Šídák’s post hoc correction; N=3–4 independent biological replicates. Data are presented as mean±SEM.
Techniques Used: Functional Assay, Expressing, Control
Figure Legend Snippet: (A)vWF mRNA expression in HBMECs 48 h after normoxia or hypoxia (6 h, 1% O₂), with or without PBM treatment, normalised to RPL13A. (B)Representative ICC images showing vWF (yellow) and nuclei (Hoechst, blue) in normoxic and hypoxic endothelial cells ±PBM. (C)Quantification of vWF protein levels, expressed as mean nuclear-normalised fluorescence intensity relative to normoxia −PBM controls. (D)Validation of vWF knockdown efficiency in siRNA-transfected endothelial cells, shown as relative vWF mRNA expression normalised to RPL13A. (E-F) Relative TEER changes (%) in endothelial monocultures and BBB tri-cultures at 24 h and 48 h under normoxic (E) and hypoxic (F) conditions following vWF silencing. Statistical comparisons for mRNA and protein expression were performed using one-way ANOVA with Šidák’s post hoc test (N=3–4 biological replicates). siRNA validation was analysed using an unpaired two-tailed t-test (N=8 biological replicates). TEER data were analysed using multiple unpaired t-tests with Holm–Šidák correction (N=4 biological replicates). Data are presented as mean±SEM.
Techniques Used: Expressing, Fluorescence, Biomarker Discovery, Knockdown, Transfection, Two Tailed Test

